CAT
Caterpillar Inc.
CAT has the edge over FC overall, supported by stronger modeled upside and stronger fundamentals.
FC
Franklin Covey Co.
FC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
FC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Healthy |
FC's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
FC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $14.83 | — |
| Cheap | 25x | $10.43 | -30% |
| Fair | 34x | $14.12 | -4.8% |
| Current | 35x | $14.83 | — |
| Expensive | 50x | $20.84 | +41% |
Historical ranges are pointers, not guarantees.
FC has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over FC on the outlook, with more favorable revenue expectations.
FC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect FC's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over FC on earnings, with stronger typical year-over-year growth.
FC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.12 | +165% |
| Q3 2026 | $0.42 | +75% |
| Q2 2026 | $0.17 | -78% |
| Q1 2026 | -$0.21 | -116% |
| Q4 2025 | -$0.12 | -108% |
| Q3 2025 | $0.24 | -86% |
| Q2 2025 | $0.79 | -41% |
| Q1 2025 | $1.33 | +9% |
| Q4 2024 | $1.47 | +15% |
FC's earnings per share have fallen from their peak: $0.42 over the past year, against $1.74 in mid-2024.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over FC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over FC on profitability, with a higher operating margin.
FC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $70M | -1.8% |
| Q2 2026 | $67.8M | +1% |
| Q1 2026 | $59.6M | +0.1% |
| Q4 2025 | $64M | -7.3% |
| Q3 2025 | $71.2M | -15% |
| Q2 2025 | $67.1M | -8.5% |
| Q1 2025 | $59.6M | -2.8% |
| Q4 2024 | $69.1M | +1% |
FC's revenue fell from its 2024 peak and has held roughly level since: $70M last quarter, down 1.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +1.3 points |
| Q2 2026 | 6.2% | +9.5 points |
| Q1 2026 | -3.4% | -0.9 points |
| Q4 2025 | -5.7% | -7.8 points |
| Q3 2025 | 11% | -10 points |
| Q2 2025 | -3.3% | -15 points |
| Q1 2025 | -2.4% | -4.8 points |
| Q4 2024 | 2.1% | -5.7 points |
FC's operating margin was 12% last quarter, up 1.3 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over FC on cash flow, with more consistent year-over-year improvement.
FC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.7M | -54% |
| Q2 2026 | -$32K | -101% |
| Q1 2026 | $15.2M | +$17.9M |
| Q4 2025 | -$1.6M | -112% |
| Q3 2025 | $5.7M | -72% |
| Q2 2025 | $4.5M | -38% |
| Q1 2025 | -$2.6M | -122% |
| Q4 2024 | $13.1M | -20% |
FC still generates free cash flow, though less than at its 2024 peak: $16M over the past year.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
FC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -3.0x | Net Cash |
| Q4 2025 | -3.5x | Net Cash |
| Q3 2025 | -3.2x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -1.3x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
FC has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
FC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.1 | Neutral |
| Stochastic | 12.4 | Oversold |
FC's weekly RSI is 33 (neutral) and its Stochastic is 12 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over FC on valuation relative to its sector.
FC PE vs Industrials Sector
| Metric | FC | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 24x | 47% above |
| PE % | 55 | 58 | 3 pts below |
FC is trading at 35x earnings, a 47% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over FC on trend strength, trading above more of its moving averages.
FC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.3 | 14% below |
| 20 week MA | $19.0 | 22% below |
| 50 week MA | $19.2 | 23% below |
| 100 week MA | $21.6 | 31% below |
| 200 week MA | $31.0 | 52% below |
FC is in a downtrend: it's below all five of its weekly moving averages, and 52% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over FC on returns for 2026, with the stronger performance.
FC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.7 | $22.3 | -34% |
| 2021 | $22.3 | $45.6 | +105% |
| 2022 | $45.6 | $47.4 | +3.9% |
| 2023 | $47.4 | $43.5 | -8.2% |
| 2024 | $43.5 | $37.0 | -15% |
| 2025 | $37.0 | $17.1 | -54% |
| 2026 YTD | $17.1 | $14.8 | -13% |
FC has finished three years in a row lower, and it's down 13% so far in 2026.